Synthetic Biologics, Inc.
Beta-lactamases with improved properties for therapy

Last updated:

Abstract:

This invention relates to, in part, compositions of beta-lactamases and methods of using these enzymes in, for example, gastrointestinal tract (GI tract) disorders such as C. difficile infection (CDI).

Status:
Grant
Type:

Utility

Filling date:

24 Jul 2020

Issue date:

1 Feb 2022